Last reviewed · How we verify

NCT03941899: QLBII

The Analgesic Effect of QLB II After Robotic Prostatectomy. (QLB II: Quadratus Lomborum Block II Type)

Completed NA Last updated 4 May 2021
What this trial tests

NA trial testing Levobupivacaine in QLB II in Postoperative Pain in 48 participants. Completed in 30 April 2021.

Timeline
6 May 2019
Primary endpoint
6 December 2020
30 April 2021

Quick facts

Lead sponsorSan Salvatore Hospital of L'Aquila
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment48
Start date6 May 2019
Primary completion6 December 2020
Estimated completion30 April 2021
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

San Salvatore Hospital of L'Aquila

Who can join

Adults 18 to 85, male only, with Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The analgesic effects of Quadratus Lomborum Block II type after robotic-assisted laparoscopic radical prostatectomy, will be assessed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Postoperative Pain

Currently open trials in the same condition.

Other San Salvatore Hospital of L'Aquila trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03941899.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing